4//SEC Filing
Cassella James V 4
Accession 0000950170-24-110921
CIK 0001563880other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 5:04 PM ET
Size
5.4 KB
Accession
0000950170-24-110921
Insider Transaction Report
Form 4
Cassella James V
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2024-09-30+400,000→ 400,000 totalExercise: $3.34Exp: 2034-09-29→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]This option was granted on September 30, 2024. The 400,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on September 30, 2025 and as to the remaining 75% of the shares in equal monthly installments thereafter, through September 30, 2028.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001353528
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 5:04 PM ET
- Size
- 5.4 KB